April 28, 2020 / 6:12 AM / a month ago

BRIEF-Bioinvent Q1 Loss After Tax Widens To SEK 32.6 Million

April 28 (Reuters) - BioInvent International AB:

* Q1 NET SALES SEK 16.7 (17.4) MILLION

* Q1 LOSS AFTER TAX SEK -32.6 (-27.8) MILLION

* STILL EXPECT EARLY RESULTS FROM PHASE I OPEN LABEL STUDY WITH A COMBINATION OF BI-1206 AND RITUXIMAB FOR TREATMENT OF NHL IN H2 2020

* TIMELINES ARE STILL SUBJECT TO POTENTIAL CHANGES AND WE WILL PROVIDE UPDATES AS NECESSARY Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below